Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial
Frank A. Giordano(University of Mannheim), Frederik Wenz(University Medical Center Freiburg), Stefanie Brehmer(Montreal Neurological Institute and Hospital), Grit Welzel(Montreal Neurological Institute and Hospital), Anke Keller(Montreal Neurological Institute and Hospital), Elisabeth Scherzinger(Montreal Neurological Institute and Hospital), Kevin Petrecca(McGill University Health Centre), Luís Souhami(McGill University Health Centre), Bettina Mürle(Montreal Neurological Institute and Hospital), Carsten Herskind(Heidelberg University), Sven Clausen(Montreal Neurological Institute and Hospital), David Schneider(Heinrich Heine University Düsseldorf), Daniel Hänggi(Heinrich Heine University Düsseldorf), Yasser Abo‐Madyan(Montreal Neurological Institute and Hospital), Peter Schmiedek, Elena Sperk(Heidelberg University), Bahman Emami(Montreal Neurological Institute and Hospital), Martin Glas(Essen University Hospital), Marcel Seiz‐Rosenhagen(Montreal Neurological Institute and Hospital), Christoph Groden
Cited by 55
Related Papers
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k